SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ICOS Corporation

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Icebrg4/12/2006 4:47:28 AM
   of 1139
 
Pfizer plans 2nd non-branded ad campaign

By THERESA AGOVINO
AP BUSINESS WRITER

NEW YORK -- In a sign of how Pfizer Inc. hopes to boost the market for erectile dysfunction drugs, the maker of impotency pill Viagra plans to launch a second non-branded, educational ad campaign about the condition on Wednesday to complement one running since late last year.

The double-dose of education comes as Pfizer tries to lift Viagra's sagging sales, which have dropped in each of the last two years.

The new campaign is designed to help men overcome embarrassment about discussing erectile dysfunction with their doctor while the ads which began last November were created to deliver more basic information about the condition, said Tim Pigot, director of the company's U.S. Viagra team.

In the latest ads, a doctor stands in an empty sports stadium to emphasize the vast number of men who suffer from the condition- half of the men over age 40. The campaign's tagline is "Just Ask Today."

The motto of the first effort is "Make the Call." It encourages men to call to receive features more information about the condition and doctor recommendations.

Growth in the erectile dysfunction market failed to live up to analysts' predictions. Many thought the market would expand after Cialis, marketed by Eli Lilly and Co. and ICOS Corp. and Levitra, sold by GlaxoSmithKline PLC and Schering-Plough Corp. entered the fray.

The competition has stifled Viagra sales. Last year, Viagra's sales slipped 2 percent to $1.65 billion are sliding 11 percent in 2004.

GlaxoSmithKline and Schering-Plough started a disease awareness campaign for Levitra last December and rolled out branded ads last month.

seattlepi.nwsource.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext